China’s Ad5-nCoV COVID-19 Vaccine Granted Conditional Marketing Authorization
This week, the China National Medical Products Administration (NMPA) granted conditional marketing authorization of Recombinant COVID-19 Vaccine (Adenovirus Type 5 […]
Pakistan Procures 10.6m Doses of Ad5-nCoV for $14 Per Dose but Seeks to Diversify with Other Vaccine Makers
CanSino Biologics, one of China’s leading vaccine makers, inked a deal with Pakistan’s government to sell the Ad5-nCoV vaccine candidate […]
Mexico Secures COVID-19 Vaccine Candidates from CanSino Biologics & Others Via COVAX
Mexico was active recently in the investigational vaccine market, securing two deals with two different companies for a total of […]
Pakistan Struggles to Recruit Volunteers for Phase 3 CanSino Biologics Vaccine Trial: Military Involved
Pakistan, the fifth most populous nation in the world, recently geared up to support a Phase 3 COVID-19 vaccine clinical […]
Will China Supply Much of the World’s Vaccine for COVID-19? WHO In Discussions to do Just That
The World Health Organization (WHO) now purportedly considers China as its strategic COVID-19 vaccine supplier as the world’s most populous […]
CanSino Biologics Inks Deal with Malaysian Holding Company to Prepare Commercialization & Distribution of Ad5-nCoV COVID-19 Vaccine
Indonesia is preparing to support the commercialization of CanSino Biologics’ Ad5-nCoV vaccine candidate as Solution Biologics Sdn Bhd (SOLBIO), a […]
CanSino Biologics’ Ad5-nCOV Tested in Phase 3 Clinical Trials in Russia
According to local reports out of Russia (Moscow Times), the Phase 3 clinical trial investigating Cansino Biologics’ COVID-19 vaccine candidate, […]
China’s Government Regulators Rushing Vaccine Candidates to Emergency Use? Other Countries Following?
As seven vaccines worldwide have moved to the final stages of testing (e.g. Phase 3 clinical trials), four of them […]
China & Canada Political Tension Likely the Culprit: COVID-19 Vaccine Trial Terminated
Canada has finally made the call to terminate the CanSino Biologics Ad5-nCoV clinical trial, the nation’s first such study targeting […]
Canada Continues to Wait for its Negotiated COVID-19 Vaccine Candidate: Still ‘Stuck’ in Chinese Customs
Although TrialSite has already reported that the Canadian government has gone to a “Plan B” for COVID-19 vaccines, the issue […]
